SARM1 and peripheral neuropathy: Also, this finding, considering the impact of a limited sample size, is in agreement with a previous study that found that loss of sensory nerve action potential amplitude occurs as a result of SARM1-dependent processes in the tail nerve in a mouse paclitaxel model of chemotherapy-induced peripheral neuropathy [41].